Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).
Adults ≥ 18 years
VV-ECMO initiated during or after emergency thoracic surgery
No opposition to data use
Pregnant women
Veno-Arterial ECMO patients
Patients under legal protection
Adults ≥ 18 years, Patients undergoing emergency thoracic procedures requiring VV-ECMO and patients treated with VV-ECMO for medical respiratory failure.
Case-only
Retrospective
Not listed
90-day all-cause mortality
90-day mortality in oncologic vs. non-oncologic thoracic surgery
Postoperative complication rates
Postoperative complication rates (hemorrhagic, thrombotic, infectious)
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Centre Hospitalier Universitaire Dijon
Collaborator
